UNSPSC 51111776: Podofilox

This classification denotes a colchicine-site binding agent with the molecular formula C22H22O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L36H50F353, chemically known as furo(3,4:6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)- but more generally known as podofilox, which bears US NIH Compound Identifier 4865. European Medicines Agency schedules Podofilox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14925MIG.

World Health Organization schedules podofilox in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, PODOFILOX remains US FDA's Preferred Term for this commodity. Podofilox bears US NLM identifiers UMLS ID C0032334 and NCI Concept Code C29368. SMILES: O1CC2C(C(C3C(C2O)CC2OCOC2C3)C2CC(OC)C(OC)C(OC)C2)C1=O.

UNSPSC 51111776 Podofilox is a Commodity code that covers pharmaceutical products, though recent state and local activity under this code shows minimal direct alignment with the podofilox designation itself. The code appears in state and local solicitations primarily as a tagging mechanism within broader pharmaceutical procurement frameworks, particularly through cooperative purchasing vehicles and piggyback arrangements. State and local governments use this code when acquiring prescription medications and related pharmaceutical supplies through established contracts and vendor networks, often leveraging multi-jurisdictional purchasing consortia to consolidate demand and achieve volume pricing. Issuing bodies soliciting under the code include state health departments (notably the Illinois Department of Public Health) and county-level public health authorities (such as Seminole County, Florida), who source these products to support public health initiatives and emergency response programs.

Recent activity centers on the Midwest and Southeast. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for a total of $2,999,999.11 over three years, supplying Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through an Invitation for Bid process. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Illinois procurement reflects standard cooperative purchasing discipline, with no set-aside programs applied; the Seminole County bid included FEMA compliance requirements and E-Verify certification mandates.